Clinical Trial Update: 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection [Phase 4]

View source ↗

Summary

Phase 4 trial comparing a 10-day versus 14-day concomitant PAMC regimen as first-line therapy to eradicate Helicobacter pylori infection; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• METRONIDAZOLE (Metronidazole)
• Pantoprazole (pantoprazole)
• clarithromycin (clarithromycin)

Snippet

Sponsor: Elpen Pharmaceutical Co. Inc. | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED